Estimates Revisions Foresee Pharmaceuticals Co., Ltd.

Stocks

End-of-day quote Taipei Exchange Other stock markets 2026-08-07			5-day change	1st Jan Change
79.50 ^TWD	-0.25%		+0.38%	-1.36%

07-09	Foresee Pharmaceuticals Co., Ltd. Announces Appointment of Brian J. Groch to Chief Commercial Officer, Effective July 1, 2026	CI
06-08	Foresee Pharmaceuticals Oral ALDH2 Activator Mirivadelgat Enters Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2A Platform Trial	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	LONZA GROUP AG
	REVOLUTION MEDICINES, INC.
	IQVIA HOLDINGS INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	ASCENDIS PHARMA A/S			-
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
	Average
	Weighted average by Cap.